Publication | Closed Access

Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go?

MedicineBronchial NeoplasmTreatment EffectivenessCancer TreatmentDifferent DosesOncologyRadiation OncologyLung CancerEgfr-mutated Lung Adenocarcinoma